Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost vs Timolol in Ocular Hypertension
NCT00579969Phase 2Terminated
- Sponsor
- University of Nebraska
- Start
- Dec 2003
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost ophthalmic solution 0.005% (TearClear TC-002) in ocular hypertension, primary open-angle glaucoma (POAG), sponsored by University of Nebraska. Started Dec 2003; status: terminated.
02
Drugs
latanoprost ophthalmic solution 0.005% (TearClear TC-002)
03
Conditions
ocular hypertensionprimary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT00579969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00579969.